LGMCX
Price
$22.18
Change
+$0.31 (+1.42%)
Updated
Apr 11 closing price
Net Assets
2.63B
RIRCX
Price
$69.13
Change
+$0.98 (+1.44%)
Updated
Apr 11 closing price
Net Assets
103.34B
Ad is loading...

LGMCX vs RIRCX

Header iconLGMCX vs RIRCX Comparison
Open Charts LGMCX vs RIRCXBanner chart's image
Loomis Sayles Global Allocation C
Price$22.18
Change+$0.31 (+1.42%)
VolumeN/A
Net Assets2.63B
American Funds Capital Income Bldr R3
Price$69.13
Change+$0.98 (+1.44%)
VolumeN/A
Net Assets103.34B
LGMCX vs RIRCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGMCX vs. RIRCX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGMCX is a Buy and RIRCX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRCX has more cash in the bank: 103B vs. LGMCX (2.63B). RIRCX pays higher dividends than LGMCX: RIRCX (2.84) vs LGMCX (0.31). LGMCX was incepted earlier than RIRCX: LGMCX (19 years) vs RIRCX (23 years). LGMCX (1.91) is less costly to investors than RIRCX (0.91). RIRCX has a lower initial minimum investment than LGMCX: RIRCX (250) vs LGMCX (2500). RIRCX annual gain was more profitable for investors over the last year : 6.31 vs. LGMCX (-5.82). RIRCX return over 5 years is better than : 39.76 vs. LGMCX (1.03).
LGMCXRIRCXLGMCX / RIRCX
Total Expense Ratio1.910.91210%
Annual Report Gross Expense Ratio1.910.91210%
Fund Existence19 years23 years-
Gain YTD-5.4470.750-727%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.63B103B3%
Annual Yield % from dividends0.312.8411%
Returns for 1 year-5.826.31-92%
Returns for 3 years-7.499.11-82%
Returns for 5 years1.0339.763%
Returns for 10 years12.9229.7843%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTIX24.57N/A
N/A
Fidelity Advisor Biotechnology I
MRGJX45.83N/A
N/A
MFS Core Equity R4
INSAX18.95N/A
N/A
Catalyst Insider Buying A
EMECX9.59N/A
N/A
Ashmore Emerging Markets Equity C
GMAYX20.32N/A
N/A
GMO Small Cap Quality I